Cellular response to latent TGF-β1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells

Experimental Cell Research

Volumn 251, Issue 1, 1999, Pages 111-120

  Ghahary, Aziz ^a   Tredget, Edward E ^a   Mi, Lei ^a   Yang, Liju ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

LTGF 1; Mannose 6 phosphate; TGF 1 activation; Type I collagen

Indexed keywords

MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; FIBROBLAST; GENETIC TRANSFECTION; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033603827     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4561     Document Type: Article

References (42)

1. Roberts A. B., Sporn M. B. The transforming growth factor-β Sporn M. B., Roberts A. B. Peptide Growth Factors and Their Receptors. 1990;421 Springer-Verlag, Berlin.
2. Ghahary A., Pannu R., Tredget E. E. Fibrogenic and anti-fibrogenic factors in wound repair. Malhotra S. K. Advances in Structural Biology. 1996;197-232 JAI Press, London.
3. Tsuji T., Okada F., Yamaguchi K., Nakamura T. Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc. Natl. Acad. Sci. USA. 87:1990;8835-8839.
4. Dallas S. L., Park-Snyder S., Miyazono K., Twardzik D., Mundy G. R., Bonewald L. B. Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J. Biol. Chem. 269:1994;6815-6821.
5. Moren A., Olofsson A., Stenman G., Sahkin P., Kanzaki T., Claesson-Welsh L., Ten Dijike P., Miyazono K., Heldin C. H. Identification and characterization of LTBP-2, a novel latent transforming growth factor-beta-binding protein. J. Biol. Chem. 269:1994;32469-32478.
6. Sporn M. B., Roberts A. B., Wakefield L. M., Associan R. K. Transforming growth factor-β: Biological function and chemical structure. Science. 233:1986;532-534.
7. Border W. A., Noble N. A. Targeting TGF-β for treatment of disease. Nature Med. 1:1995;1000-1001.
8. Ignotz R. A., Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:1986;4337-4345.
9. Sporn M. B., Roberts A. B., Wakefield L. M., de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol. 105:1987;1039-1045.
10. Allen J. B., Wong H. L., Costa P., Simon G. L., Bienkowski M. J., Wahl S. M. Suppression of monocyte function and differential regulation of IL-1 and IL-4 contribute to resolution of experimental arthritis. J. Immunol. 151:1993;4344-4351.
11. Overall C., Wrana J. L., Sodeck J. Independent regulation of collagenase, 72 kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor beta. J. Biol. Chem. 264:1989;1860-1869.
12. Edwards D. R., Murphy G., Reynolds J. J., Whitman S. E., Docherty A. J. P., Angel P., Heath J. K. Transforming growth factor-β stimulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;1899-1904.
13. Wakefield L. M., Smith D. M., Masui T., Harris C. C., Sporn M. B. Distribution and modulation of the cellular receptor for transforming growth factor-beta. J. Cell. Biol. 105:1987;965-975.
14. Postlethwaite A. E., Keski-Oja J., Moses H. L., Kang A. H. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J. Exp. Med. 165:1987;251-256.
15. Border W. A., Noble N. A. Fibrosis linked to TGF-β in yet another disease. J. Clin. Invest. 96:1995;655-656.
16. Wakefield L. M., Smith D. M., Flanders K. C., Sporn M. B. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J. Biol. Chem. 263:1988;7646-7654.
17. Lyons R. M., Keski-Oja J., Moses H. L. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell Biol. 106:1988;1659-1665.
18. Purchio A. F., Cooper J. A., Brunner A. M., Lioubin M., Gentry L. E., Kovacina K. S., Roth R. A., Marquardt H. Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. J. Biol. Chem. 263:1988;14211-14215.
19. MacDonald R. G., Pfeffer S. R., Coussens L., Tepper M. A., Brocklebank C. M., Mole J. E., Anderson J. K., Chen E., Czech M. P., Ullrich A. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science. 239:1988;1134-1137.
20. Dennis P. A., Rifkin D. B. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA. 88:1991;580-584.
21. DeBleser P. J., Jannes P., Van Buul-Offers S. C., Hoogerbrugge C. M., Van Schravendijk C. F. H., Niki T., Rogiers V., Van Den Brande J. L., Wisse E., Geerts A. Insulin like growth factor-II/mannose 6-phosphate receptor is expressed on CC14-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology. 21:1995;1429-1437.
22. Ghahary, A., Tredget, E. E., Chang, L. J., Scott, P. G., and Shen, Q.1998. Genetically modified dermal keratinocytes express high levels of transforming growth factor-β1. J. Invest. Dermatol.110, 800-805, 1998.
23. Palsson B., Andreadis S. The physico-chemical factors that govern retrovirus-mediated gene transfer. Exp. Hematol. 25:1997;94-102.
24. Danielpour D. Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1. J. Immunol. Methods. 158:1993;17-25.
25. Gabel C. A., Goldberg D. E., Kornfeld S. Identification and characterization of cells deficient in the mannose-6-phosphate receptor: Evidence for an alternate pathway for lysosomal enzyme targeting. Proc. Natl. Acad. Sci. USA. 80:1983;775-779.
26. Nolan C. M., Kyle J. W., Watanable H., Sly W. S. Binding of insulin-like growth factor II (IGF-II) by human cation-independent mannose-6-phosphate receptor/IGF-II receptor expressed in receptor-deficient mouse L cells. Cell Res. 1:1990;197-213.
27. Kyle J. W., Nolan C. M., Oshima A., Sly W. S. Expression of human cation-independent mannose 6-phosphate receptor cDNA in receptor-negative mouse P388D1 cells following gene transfer. J. Biol. Chem. 263:1988;16230-16235.
28. Watanbe H., Grubb J. H., Sly W. S. The overexpressed human 46-kDa mannose 6-phosphate receptor mediates endocytosis and sorting of B-glucuronidase. Proc. Natl. Acad. Sci. USA. 87:1990;8036-8040.
29. Ghahary A., Shen Q., Shen Y. J., Scott P. G., Tredget E. E. Induction of transforming growth factor β1 by insulin-like growth factor-1 in dermal fibroblasts. J. Cell. Physiol. 174:1998;301-309.
30. Ghahary A., Shen Y. J., Scott P. G., Tredget E. E. Expression of mRNA for transforming growth factor-β1 is reduced in hypertrophic scar and normal dermal fibroblasts following serial passage in vitro. J. Invest. Dermatol. 103:1994;684-686.
31. Wang R., Ghahary A., Shen Y. J., Scott P. G., Tredget E. E. Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms. J. Invest. Dermatol. 106:1996;419-427.
32. Ghahary A., Cheng K. W. Identification and characterization of the Beta-adrenergic receptor on neuroblastoma Xglioma hybrid NG108-15 cells. Cell. Mol. Neurobiol. 10:1990;337-350.
33. Roberts A. B., Assoian R. K., Sporn M. B., Smith J. M., Roche S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H., Fauci A. S. Transforming growth factor beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA. 83:1986;4167-4171.
34. Danielpour D., Dart L. L., Flanders K. C., Roberts A. B., Sporn M. B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells. J. Cell. Physiol. 138:1989;79-86.
35. Ghahary A., Tredget E. E., Shen Q. Insulin like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-β1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system. J. Cell. Physiol. 180:1999;61-70.
36. Morgan D. O., Edman J. C., Standing D. N., Fried V. A., Smith M. C., Roth R. A., Rutter W. J. Insulin-like growth factor-II as a multifunctional binding protein. Nature. 329:1987;301-307.
37. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu. Rev. Biochem. 61:1992;307-330.
38. Munger J. S., Harpel J. G., Gleizes P. E., Mazzieri R., Nunes I., Rifkin D. B. Latent transforming growth factor-β: Structural features and mechanism of activation. Kidney Int. 51:1997;1376-1382.
39. Kovacina K. S., Steele-Perkins G., Purchio A. F., Lioubin M., Miyazono K., Heldin C. H., Roth R. A. Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem. Biophys. Res. Commun. 160:1989;393-403.
40. Jullien P., Breg T. M., Lawrence D. A. Acid cellular environments: Activation of latent TGF-beta and sensitization of cellular responses to TGF-beta and EGF. Int. J. Cancer. 43:1989;886-891.
41. Kirschenlohr H. L., Metcalfe J. C., Weissberg P. L., Grainger D. J. Adult human smooth muscle cells in culture produce active TGF-beta. Am. J. Physiol. 63:1993;C571-C576.
42. Schults-Cherry S., Ribeiro S., Gentry L., Murphy-Ullrich G. E. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J. Biol. Chem. 269:1994;26775-26782.